Schrodinger (SDGR)
(Delayed Data from NSDQ)
$20.09 USD
-0.39 (-1.90%)
Updated Aug 21, 2024 04:00 PM ET
After-Market: $20.10 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Schrodinger, Inc. (SDGR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$34.82 | $50.00 | $25.00 | 70.02% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Schrodinger, Inc. comes to $34.82. The forecasts range from a low of $25.00 to a high of $50.00. The average price target represents an increase of 70.02% from the last closing price of $20.48.
Analyst Price Targets (11)
Broker Rating
Schrodinger, Inc. currently has an average brokerage recommendation (ABR) of 1.55 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.55 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, eight are Strong Buy, representing 72.73% of all recommendations. A month ago, Strong Buy represented 72.73%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/SDGR.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 7 | 7 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.55 | 1.55 | 1.55 | 1.60 | 1.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/31/2024 | Piper Sandler | Joseph M Catanzaro | Strong Buy | Strong Buy |
7/11/2024 | KeyBanc Capital Markets | Scott Schoenhaus | Strong Buy | Strong Buy |
7/2/2024 | SVB Securities | Mani Foroohar | Not Available | Strong Buy |
5/2/2024 | Craig-Hallum | Matthew G Hewitt | Strong Buy | Strong Buy |
5/1/2024 | BMO Capital Markets | Evan Seigerman | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Steven Mah | Strong Buy | Strong Buy |
3/1/2024 | Goldman Sachs | Chris Shibutani | Hold | Hold |
2/29/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.55 |
ABR (Last week) | 1.55 |
# of Recs in ABR | 11 |
Average Target Price | $34.82 |
LT Growth Rate | 11.90% |
Industry | Medical Info Systems |
Industry Rank by ABR | 67 of 253 |
Current Quarter EPS Est: | -0.41 |